NCT03860402

Brief Summary

The investigators are going to compare the onset and duration of nerve blockage with the use of pre-warmed (38°C) and room temperature (20°C) local anesthetic solutions (ropivacaine and fentanyl) on epidural anesthesia for cesarean section, and compare the incidence of complications such as hypotension, nausea and vomiting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

March 6, 2020

Status Verified

March 1, 2020

Enrollment Period

11 months

First QC Date

January 25, 2019

Last Update Submit

March 5, 2020

Conditions

Keywords

pre-warmed epiural anestheticsepidural anesthesia

Outcome Measures

Primary Outcomes (1)

  • Onset time of epidural anesthesia (up to T6 level)

    After the administration of epidural local anesthetics the sensory block level is checked every 2 minutes for 20 minutes, every 10 minutes during operating period, and every 10 minutes for 60 minutes in the recovery room. The sensory block level is assessed using the pinprick test method.

    During the operation

Secondary Outcomes (2)

  • Incidence of hypotension

    During the operation

  • Incidence of nausea and vomiting

    From the time of epidural injection to 1 hour after entering recovery room

Study Arms (2)

Pre-warmed drug

Pre-warmed (38°C) ropivacaine (7.5mg/ml) 19ml and fentanyl 50ug are injected via the epidural route at the L3-4 interspace.

Other: Temperature

Room temperature drug

Room temperature (20°C) ropivacaine (7.5mg/ml) 19ml and fentanyl 50ug are injected via the epidural route at the L3-4 interspace.

Interventions

temperature of drug

Pre-warmed drug

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Among the pregnant women who were administered cesarean section in this study, those who agreed to participate in this study.

You may qualify if:

  • Among the pregnant women who were administered cesarean section in this study, those who agreed to participate in this study.

You may not qualify if:

  • Fetal distress requiring fast delivery.
  • Patients with hypersensitivity, allergic response, resistance to the drugs used in this study (fentanyl, ropivacaine, lidocaine).
  • Patients who is not possible for regional anesthesia
  • Patients who refused to participate in this study.
  • Patients who cannot read or understand the agreement.
  • Patients whose weight is less than 50kg or exceeds 100kg.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kangnam sacred heart hospital

Seoul, Yeongdeungpo-gu, KS013, South Korea

Location

MeSH Terms

Interventions

Temperature

Intervention Hierarchy (Ancestors)

ThermodynamicsPhysical PhenomenaWeatherAtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment, ControlledEnvironment and Public Health

Study Officials

  • Eun Mi Choi, MD

    Hallym University Kangnam Sacred Heart Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 25, 2019

First Posted

March 1, 2019

Study Start

February 1, 2019

Primary Completion

December 31, 2019

Study Completion

January 31, 2020

Last Updated

March 6, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations